(Q40321521)

English

An intact sequence-specific DNA-binding domain is required for human cytomegalovirus-mediated sequestration of p53 and may promote in vivo binding to the viral genome during infection

scientific article published on 7 February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

An intact sequence-specific DNA-binding domain is required for human cytomegalovirus-mediated sequestration of p53 and may promote in vivo binding to the viral genome during infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Kyle Rosenke

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Melanie A Samuel

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Eric T McDowell

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Melissa A Toerne

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Elizabeth A Fortunato

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

7 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

number of pages

16

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

348

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

19-34

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

p53 and regulation of DNA damage recognition during nucleotide excision repair

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Regulation of p53 function and stability by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Physical and functional interaction between p53 and the Werner's syndrome protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

The p53 gene and its role in human brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Role of human cytomegalovirus immediate-early proteins in cell growth control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

In vitro analysis of the dominant negative effect of p53 mutants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

The role of tetramerization in p53 function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

The dominant-negative effect of p53 mutants and p21 induction in tetraploid G1 arrest depends on the type of p53 mutation and the nature of the stimulus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Inhibition of DNA replication factor RPA by p53.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Definition of a consensus binding site for p53

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

HCMV IE2-mediated inhibition of HAT activity downregulates p53 function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Utilization of the CBP but not the p300 co-activator by human T-lymphotropic virus type-2 Tax for p53 inhibition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Wild-type p53 negatively regulates the expression of a microtubule-associated protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Why is p53 acetylated?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

SUMO-1 modification activates the transcriptional response of p53

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

DNA damage activates p53 through a phosphorylation-acetylation cascade

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

p53 downstream targets and chemosensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Inhibition of cell division by the human cytomegalovirus IE86 protein: role of the p53 pathway or cyclin-dependent kinase 1/cyclin B1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Potential role of human cytomegalovirus and p53 interaction in coronary restenosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Kinetics of p53 binding to promoter sites in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Characterization of the human p53 gene promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

p53 modulation of TFIIH-associated nucleotide excision repair activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Human cytomegalovirus immediate early proteins upregulate endothelial p53 function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Functional interaction of p53 and BLM DNA helicase in apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Role of p14(ARF) in replicative and induced senescence of human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Regulation of p53 responses by post-translational modifications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Association of p53 and MSH2 with recombinative repair complexes during S phase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

p53 C-terminal interaction with DNA ends and gaps has opposing effect on specific DNA binding by the core

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

based on heuristic

inferred from DOI database lookup

Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction of a cloned library of the EcoRI fragments from the human cytomegalovirus genome (strain AD169)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.013

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.12.013

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40321521&oldid=1895071745"